wtf13 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
wtf13; wtf12; SPCC162.04c; Meiotic driver wtf13
Target Names
wtf13
Uniprot No.

Target Background

Function
This antibody promotes unequal transmission of alleles from the parental zygote to progeny spores. It acts as a poison/antidote system, where the poison and antidote proteins are produced from the same locus. The poison component functions in a trans-acting manner and targets all spores within an ascus. Conversely, the antidote component is spore-specific, leading to the poisoning of all progeny that do not inherit the allele. This antibody localizes isoform 2 to the vacuole, facilitating its degradation. Beyond suppressing isoform 2, it also suppresses S. pombe strain FY29033 wtf18 isoform 2. Notably, it forms toxic aggregates that disrupt spore maturation.
Database Links
Protein Families
WTF family
Subcellular Location
[Isoform 1]: Spore membrane; Multi-pass membrane protein. Vacuole membrane; Multi-pass membrane protein.; [Isoform 2]: Ascus epiplasm. Cytoplasm. Spore membrane; Multi-pass membrane protein. Vacuole membrane; Multi-pass membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein.

Q&A

What is wtf13 and why are antibodies used in its research?

Based on the scientific literature, wtf13+ appears to be a gene studied in model organisms, particularly in relation to transcriptional regulation studies. Antibodies are critical tools for investigating wtf13 expression and regulation, especially through techniques like chromatin immunoprecipitation (ChIP). In research contexts, anti-mouse IgG antibodies have been used to immunoprecipitate chromatin fragments where transcriptional regulators like Cuf2-TAP bind to wtf13+ promoter regions . This enables researchers to quantify protein-DNA interactions at specific genomic loci, providing insights into the mechanisms controlling wtf13 expression.

How are antibodies typically employed in wtf13 promoter region studies?

Antibodies serve as essential tools for analyzing protein binding to wtf13 promoter regions. In ChIP experiments, researchers have used resin-bound anti-mouse IgG antibodies to immunoprecipitate chromatin at specific timepoints after meiotic induction. The enrichment of wtf13+ promoter regions is then quantified through qPCR relative to control DNA regions (such as 18S ribosomal DNA) . This approach allows precise determination of transcription factor occupancy at specific wtf13 promoter regions, helping elucidate the regulatory mechanisms governing its expression.

What relationship exists between Cuf2 and wtf13?

Research indicates that Cuf2 functions as a transcriptional co-regulator that interacts with the wtf13+ promoter. ChIP assays have demonstrated significant Cuf2-TAP occupancy at specific regions of the wtf13+ promoter, suggesting a direct regulatory relationship. This interaction appears particularly important during meiosis, as indicated by studies using synchronized meiotic induction systems . The specific binding pattern of Cuf2 to the wtf13+ promoter implies a potentially important role in regulating wtf13 expression during meiotic progression.

What are optimal conditions for chromatin immunoprecipitation when studying wtf13 promoter interactions?

Effective ChIP protocols for studying wtf13 promoter interactions require careful optimization of several parameters. Based on published methodologies, synchronized cell populations (using systems like pat1-114 temperature-sensitive mutations) ensure uniform progression through biological processes like meiosis. Chromatin should be immunoprecipitated using high-affinity antibodies (such as resin-bound anti-mouse IgG) at precisely defined timepoints after biological induction . When analyzing wtf13+ promoter regions by qPCR, researchers should design primers targeting specific regulatory regions of interest. The binding of transcription factors to these regions should be calculated as enrichment relative to control regions, with results expressed as fold enrichment to enable quantitative comparisons across conditions and timepoints.

How can RNA polymerase II occupancy at the wtf13 locus be effectively measured?

To measure RNA polymerase II occupancy at the wtf13 locus, researchers have employed comparative ChIP analyses between wild-type (cuf2+/cuf2+) and knockout (cuf2Δ/cuf2Δ) strains. The experimental approach involves synchronously inducing meiosis in cultures, followed by ChIP to analyze RNA polymerase II binding patterns. Primers targeting specific regions of the wtf13+ gene (designated as ORF B and ORF C in the literature) are used for qPCR analysis . This methodology enables determination of how transcriptional regulators like Cuf2 affect RNA polymerase II recruitment and processivity along the wtf13+ gene, providing mechanistic insights into transcriptional regulation.

What approaches can resolve temporal dynamics of wtf13 regulation during meiosis?

Studying the temporal dynamics of wtf13 regulation during meiosis requires integrated methodological approaches. Time-course ChIP experiments at defined intervals throughout meiotic progression can map dynamic changes in transcription factor binding to the wtf13 promoter. Combining ChIP for transcription factors with parallel measurements of RNA Polymerase II occupancy provides correlation between factor binding and transcriptional activity . These approaches should ideally be performed in synchronized cell populations to ensure uniform progression through meiosis. Additionally, complementing ChIP data with RNA expression analyses helps connect promoter occupancy patterns with gene expression outcomes, providing a comprehensive view of wtf13 temporal regulation.

What methodological approaches are most effective for designing specific antibodies against wtf13-related proteins?

Designing specific antibodies against wtf13-related proteins requires sophisticated methodological approaches. Recent advances employ biophysics-informed modeling approaches trained on experimental data from phage display selections. These models associate each potential ligand with distinct binding modes, enabling the prediction and generation of antibody variants with customized specificity profiles . For generating wtf13-specific antibodies, researchers would first conduct phage display experiments against multiple related antigens, then apply computational models to disentangle the different binding modes associated with each epitope. This integrated approach allows for the design of antibodies with either high specificity for wtf13 or controlled cross-reactivity with related proteins.

How do researchers distinguish between designing cross-specific versus highly specific antibodies?

The design of antibodies with different specificity profiles requires distinct methodological approaches. For cross-specific antibodies that interact with multiple ligands, researchers jointly minimize the energy functions associated with all desired targets. Conversely, for highly specific antibodies that discriminate between closely related ligands, researchers minimize energy functions for the desired target while maximizing functions for undesired ligands . This computational approach enables the generation of novel antibody sequences with predefined binding profiles not present in natural repertoires. For wtf13 research, this methodology allows creation of antibodies that either recognize conserved epitopes across related proteins or specifically bind uniquely to wtf13, depending on experimental requirements.

How can biophysical models enhance antibody development for wtf13 research?

Biophysical modeling represents a significant advancement for wtf13 antibody development by enabling prediction and generation of antibody variants beyond those observed in experimental selections. These models parameterize binding energies for different modes using neural networks trained on experimental data . For wtf13 research, such models can be applied to design antibodies with precisely defined specificity profiles—either with high affinity specifically for wtf13 or with controlled cross-reactivity to related proteins. The integration of computational prediction with experimental validation through techniques like phage display provides a powerful approach for generating antibodies with superior performance characteristics tailored to specific wtf13 research applications.

What comprehensive validation approaches ensure wtf13 antibody specificity?

Validating antibody specificity is critical for reliable wtf13 research. A comprehensive validation protocol should include multiple complementary approaches. Western blot analysis comparing wild-type samples with wtf13 deletion mutants confirms antibody specificity at the protein level. Immunoprecipitation followed by mass spectrometry identifies all proteins recognized by the antibody. Competitive binding assays with purified wtf13 protein or peptides provide quantitative measures of specificity . Additionally, testing antibody performance across multiple experimental contexts relevant to intended applications ensures robust performance under varied conditions. Using multiple antibodies targeting different wtf13 epitopes can provide further validation through concordant results.

What critical parameters require optimization in ChIP-qPCR protocols for wtf13 studies?

Optimizing ChIP-qPCR protocols for wtf13 studies requires careful attention to several critical parameters. Cell synchronization ensures uniform biological states at sampling timepoints (e.g., 6 hours post-meiotic induction) . Crosslinking conditions must efficiently capture protein-DNA interactions without over-fixation. Sonication parameters should generate chromatin fragments of appropriate size (typically 200-500 bp). Antibody selection should prioritize high specificity and affinity. qPCR primers must target specific regions within the wtf13+ promoter with verified efficiency and specificity. Appropriate controls, including input samples and non-specific antibody precipitations, are essential for accurate data interpretation. Standardized enrichment calculations enable meaningful comparisons across experiments.

How should researchers approach inconsistent results when using antibodies in wtf13 studies?

When facing inconsistent results in wtf13 antibody experiments, researchers should systematically evaluate multiple factors. Antibody quality and batch variation can be addressed by testing different lots and generating large batches for long-term consistency. Experimental conditions including cell synchronization, fixation times, and buffer compositions should be precisely controlled. Technical variations in immunoprecipitation, washing, and elution steps must be standardized . Sample preparation should ensure consistent cell growth and harvesting procedures. Data analysis should apply uniform normalization methods across experiments. Increasing biological replicates helps distinguish technical from biological variation. Comprehensive positive and negative controls should be included in every experiment to provide benchmarks for expected outcomes.

How can machine learning improve antibody design for wtf13 research?

Machine learning approaches offer significant advantages for designing wtf13-specific antibodies. Biophysics-informed models that incorporate deep neural networks can parametrize binding energies for different epitopes, enabling precise control over antibody specificity . These models can be trained on experimental data from phage display selections against wtf13 and related proteins, then used to generate novel antibody sequences with customized binding profiles. The computational approach effectively disentangles different binding modes associated with specific epitopes, allowing researchers to design antibodies that selectively recognize wtf13 while excluding closely related proteins. This integration of computational prediction with experimental validation represents a powerful methodology for developing superior wtf13-specific research tools.

What computational methods help analyze complex ChIP-seq data for wtf13 binding sites?

While traditional ChIP-qPCR approaches target specific wtf13 promoter regions as described in the literature , genome-wide ChIP-seq analysis requires sophisticated computational methods. Peak-calling algorithms identify significant binding sites across the genome, while differential binding analysis compares occupancy patterns between experimental conditions. Motif discovery tools can identify sequence elements associated with protein binding to wtf13 regulatory regions. Integration with other genomic data types, such as RNA-seq or ATAC-seq, provides context for functional interpretation of binding events. Visualization tools that support multiple data tracks enable researchers to examine wtf13 regulation in genomic context. These computational approaches transform raw sequencing data into biologically meaningful insights about wtf13 regulation.

How do autoantibody research methodologies inform understanding of wtf13-related processes?

Research on autoantibodies provides methodological insights applicable to wtf13 antibody studies. Studies on anti-ADAMTS13 autoantibodies have employed affinity purification using specific matrices followed by protein G chromatography to isolate antibodies from complex biological samples . Similar approaches could isolate wtf13-specific antibodies from experimental systems. Additionally, methodologies for characterizing autoantibody properties—including affinity measurements using Biacore and functional inhibition assays—provide templates for wtf13 antibody characterization . Understanding how autoantibodies recognize specific epitopes on target proteins can inform epitope mapping strategies for wtf13 antibodies, enhancing their application in research contexts.

What considerations apply when developing mouse models for studying wtf13 antibody functions?

Development of mouse models for wtf13 antibody studies would benefit from methodologies established for other research antibodies. The generation of inhibitory antibodies against murine proteins has been successfully demonstrated using hybridoma technology to produce monoclonal antibodies (mAbs) . Testing panels of antibodies for specific functional effects provides a systematic approach to identifying those with desired properties. In vivo validation can confirm the efficacy and duration of antibody-mediated effects, as demonstrated by studies showing that single bolus injections of inhibitory antibodies can produce long-term effects (>7 days) . These established methodologies provide valuable frameworks for developing mouse models to study wtf13 antibody functions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.